Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARS PHARMACEUTICALS INC

14.38
-0.6200-4.13%
Volume:1.11M
Turnover:16.40M
Market Cap:1.41B
PE:179.75
High:15.44
Open:15.25
Low:14.32
Close:15.00
Loading ...

ARS Pharmaceuticals up 5.8% Premarket After Q4 Results Beat

THOMSON REUTERS
·
20 Mar

Earnings Flash (SPRY) ARS Pharmaceuticals Posts Q4 Revenue $86.6M

MT Newswires Live
·
20 Mar

Earnings Flash (SPRY) ARS Pharmaceuticals Posts Q4 EPS $0.48, vs. FactSet Est of $-0.04 Loss

MT Newswires Live
·
20 Mar

ARS Pharmaceuticals Says $314M In Cash, Cash Equivalents, And Short-term Investments At Year-end 2024, Supporting An Increased Investment In Commercialization In 2025 While Maintaining An Operating Runway Of At Least Three Years

Benzinga
·
20 Mar

ARS Pharmaceuticals Q4 2024 GAAP EPS $0.48 May Not Be Comparable To $(0.14) Estimate, Sales $86.60M May Not Be Comparable To $15.82M Estimate

Benzinga
·
20 Mar

ARS Pharmaceuticals: Financial Position Is Expected to Support Operating Plans for at Least Next 3 Years

THOMSON REUTERS
·
20 Mar

ARS Pharmaceuticals Inc - Q4 2024 Revenue $86.6 Million

THOMSON REUTERS
·
20 Mar

Press Release: ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Dow Jones
·
20 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

ARS Pharmaceuticals Initiated at Sector Outperform by Scotiabank

Dow Jones
·
08 Mar

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.
·
08 Mar

ARS Pharmaceuticals initiated with an Outperform at Scotiabank

TIPRANKS
·
07 Mar

BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax

Reuters
·
06 Mar

ARS Pharmaceuticals Shares up 1.6% on Expanded US Approval for Allergic Reaction Nasal Spray

THOMSON REUTERS
·
06 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Scienture, ARS Pharma, BrightSpring Health

Reuters
·
06 Mar

BUZZ-ARS Pharma rises on expanded US approval for allergic reaction nasal spray

Reuters
·
06 Mar

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
06 Mar

ARS Pharmaceuticals Says US FDA Approves Lower Dosage of Neffy Nasal Spray

MT Newswires Live
·
06 Mar